| # | Drug | Count |
|---|---|---|
| 0 | PREDNISONE | 78 |
| 1 | CYTARABINE | 71 |
| 2 | CYCLOPHOSPHAMIDE | 66 |
| 3 | CYCLOPHOSPHAMIDE FOR INJECTION | 66 |
| 4 | CYCLOPHOSPHAMIDE INJECTION, SOLUTION | 66 |
| 5 | METHOTREXATE SODIUM | 61 |
| 6 | METHYLPREDNISOLONE | 61 |
| 7 | METHOTREXATE | 60 |
| 8 | DEXAMETHASONE | 57 |
| 9 | DEXAMETHASONE 1.5 MG | 57 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | SODIUM GLYCEROPHOSPHATE | 6 | 0.0165 |
| 1 | AMLODIPINE BESYLATE AND ATORVASTATIN CALCIUM | 1 | 0.0115 |
| 2 | SMOFLIPID | 7 | 0.0080 |
| 3 | PORACTANT ALFA | 5 | 0.0068 |
| 4 | RALTEGRAVIR | 26 | 0.0050 |
| 5 | VANCOMYCIN HYDROCHLORIDE | 39 | 0.0047 |
| 6 | POTASSIUM ACETATE | 6 | 0.0041 |
| 7 | FLUDEOXYGLUCOSE F-18 | 1 | 0.0035 |
| 8 | DORAVIRINE, LAMIVUDINE, AND TENOFOVIR DISOPROXIL FUMARATE | 1 | 0.0032 |
| 9 | CEFPODOXIME PROXETIL | 3 | 0.0030 |
| # | Drug class | Count |
|---|---|---|
| 0 | Corticosteroid [EPC] | 195 |
| 1 | Nucleoside Metabolic Inhibitor [EPC] | 119 |
| 2 | Alkylating Drug [EPC] | 80 |
| 3 | Folate Analog Metabolic Inhibitor [EPC] | 60 |
| 4 | Nonsteroidal Anti-inflammatory Drug [EPC] | 47 |
| 5 | Tumor Necrosis Factor Blocker [EPC] | 46 |
| 6 | Glycopeptide Antibacterial [EPC] | 39 |
| 7 | Azole Antifungal [EPC] | 37 |
| 8 | BCL-2 Inhibitor [EPC] | 37 |
| 9 | Aminosalicylate [EPC] | 32 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Surfactant [EPC] | 5 | 0.0043 |
| 1 | Lipid Emulsion [EPC] | 7 | 0.0026 |
| 2 | Asparagine-specific Enzyme [EPC] | 18 | 0.0013 |
| 3 | Anthracycline Topoisomerase Inhibitor [EPC] | 3 | 0.0012 |
| 4 | CD33-directed Immunoconjugate [EPC] | 4 | 0.0011 |
| 5 | Macrolide Antibacterial [EPC] | 1 | 0.0010 |
| 6 | Antimetabolite Immunosuppressant [EPC] | 17 | 0.0008 |
| 7 | Echinocandin Antifungal [EPC] | 6 | 0.0007 |
| 8 | Lipid-based Polyene Antifungal [EPC] | 9 | 0.0007 |
| 9 | CD22-directed Immunoconjugate [EPC] | 2 | 0.0007 |